The restoration of the depleted miR-143 in plasma is a novel anticancer treatment for esophageal squamous cell carcinoma

被引：0
|
作者：
Kiuchi, Jun [1 ]
Komatsu, Shuhei [1 ]
Imamura, Taisuke [1 ]
Nishibeppu, Keiji [1 ]
Ohashi, Takuma [1 ]
Kishimoto, Takuma [1 ]
Takashima, Yusuke [1 ]
Kamiya, Hajime [1 ]
Arita, Tomohiro [1 ]
Shimizu, Hiroki [1 ]
Yamamoto, Yusuke [1 ]
Konishi, Hirotaka [1 ]
Shiozaki, Atsushi [1 ]
Fujiwara, Hitoshi [1 ]
Otsuji, Eigo [1 ]
机构：
[1] Kyoto Pref Univ Med, Div Digest Surg, Kyoto, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P15-3-5
引用
收藏
页码：1043 / 1043
页数：1
相关论文
共 50 条
  • [1] MiRNA profile in esophageal squamous cell carcinoma:Downregulation of miR-143 and miR-145
    Bing-Li Wu
    World Journal of Gastroenterology, 2011, 17 (01) : 79 - 88
  • [2] MiRNA profile in esophageal squamous cell carcinoma: Downregulation of miR-143 and miR-145
    Wu, Bing-Li
    Xu, Li-Yan
    Du, Ze-Peng
    Liao, Lian-Di
    Zhang, Hai-Feng
    Huang, Qiao
    Fang, Guo-Qiang
    Li, En-Min
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (01) : 79 - 88
  • [3] MiR-143 inhibits tumour progression by targeting STAT3 in esophageal squamous cell carcinoma
    Li, B.
    Liu, S. C. H. Et. I. Jia
    Mao, S. C. H. Et. I. Yu
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S479 - S479
  • [4] miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma
    Mao, Yu
    Liu, Jia
    Zhang, Dakai
    Li, Baosheng
    TUMOR BIOLOGY, 2016, 37 (07) : 9009 - 9022
  • [5] The Cluster of miR-143 and miR-145 Affects the Risk for Esophageal Squamous Cell Carcinoma through Co-Regulating Fascin Homolog 1
    Liu, Ran
    Liao, Juan
    Yang, Miao
    Sheng, Jingyi
    Yang, Hao
    Wang, Yi
    Pan, Enchun
    Guo, Wei
    Pu, Yuepu
    Kim, Sun Jung
    Yin, Lihong
    PLOS ONE, 2012, 7 (03):
  • [6] Depleted Tumor Suppressor miR-655 in Plasma Contributes to Poor Outcomes and Is a Novel Therapeutic Target in Esophageal Squamous Cell Carcinoma
    Kiuchi, Jun
    Komatsu, Shuhei
    Ichikawa, Daisuke
    Imamura, Taisuke
    Kosuga, Toshiyuki
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Otsuji, Eigo
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2017, 225 (04) : S189 - S189
  • [7] Plasma miR-126 and miR-143 as Potential Novel Biomarkers for Cerebral Atherosclerosis
    Gao, Jing
    Yang, Shuna
    Wang, Kun
    Zhong, Qianwei
    Ma, Aijun
    Pan, Xudong
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2019, 28 (01): : 38 - 43
  • [8] miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma (vol 37, pg 9009, 2016)
    Mao, Yu
    Liu, Jia
    Zhang, Dakai
    Li, Baosheng
    TUMOR BIOLOGY, 2016, 37 (11) : 15343 - 15346
  • [9] Association between the rs3733846 in the flanking region of miR-143/145 and risk of cervical squamous cell carcinoma
    Gong, Jianyu
    Jiang, Jike
    Qu, Jianwen
    Li, Ju
    Chen, Xin
    Ruan, Zhiguo
    Lu, Gangxu
    He, Yuxiao
    He, Xiaoshan
    Sun, Ruifen
    BIOMARKERS IN MEDICINE, 2021, 15 (11) : 891 - 897
  • [10] RETRACTION: MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma (Retraction of Vol 373, Pg 97, 2016)
    Liu, Jia
    Mao, Yu
    Zhang, Dakai
    Hao, Shengnan
    Zhang, Zicheng
    Li, Zhenjiang
    Li, Baosheng
    CANCER LETTERS, 2018, 422 : 133 - 133
12345